Wedbush analyst Gerald Pascarelli initiated coverage of Curaleaf with an Outperform rating and $8.50 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CURLF:
- CURLF, GTBIF, or IIPR: Which “Strong Buy” Cannabis Stock has Higher Upside Potential?
- Curaleaf (TSE:CURA) Misses Q3-2022 Earnings Estimates, but There’s Potential Here
- Curaleaf Reports Third Quarter 2022 Results
- Cannabis Stocks are on a High after Biden Calls for Favorable Reforms
- Curaleaf Completes Acquisition of Tryke Companies